Clinical trial Recruiting at 1 site Interventional Ages 7 to 30

Ketogenic (modified Atkins) diet for hypothalamic tumor–related central obesity

Official title: Single-arm, Open-label, Single-center, Non-profit Interventional Clinical Trial on the Effects of the Ketogenic Diet in Patients With Brain Tumors and Central Obesity

Run by Meyer Children's Hospital IRCCS · NCT07396896 · Data updated 2026-11-12

This trial will try a modified Atkins ketogenic diet to help children and young adults with hypothalamic-chiasmatic tumors lose excess weight.

Quick facts

Study typeInterventional
Ages7 Years to 30 Years
SexAll
Enrollment30 (estimated)
SponsorMeyer Children's Hospital IRCCS
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Florence, Florence)
StatusRecruiting
StartedMay 8, 2025
Main results expectedApril 2028
Study endsApril 2028
Registry record updatedFebruary 9, 2026
Trial IDNCT07396896 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and young adults aged 7–30 with a confirmed hypothalamic-chiasmatic tumor, BMI above the 97th percentile (after age 5), and adequate performance status who can follow a ketogenic diet are ideal candidates.

Probably not a fit

Patients with inherited fatty-acid oxidation or related metabolic disorders, those unable to adhere to a ketogenic eating plan, or whose obesity is not driven by hypothalamic injury are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional, single-center protocol enrolls patients aged 7–30 who have hypothalamic-chiasmatic tumors and severe hypothalamic obesity that is refractory to medical therapy. Participants will follow a modified Atkins ketogenic diet with regular clinical monitoring, metabolic laboratory testing, and safety checks, and individuals with inherited fatty-acid oxidation or related metabolic enzyme deficiencies are excluded. The research is conducted at Meyer Children's Hospital IRCCS in Florence and requires informed consent from patients and guardians for minors. Primary outcomes will focus on changes in weight/BMI and metabolic/endocrine markers, along with measures of tolerability and adherence.

Why it matters

Potential benefit: If successful, the diet could reduce excessive weight and improve metabolic health and quality of life for patients with hypothalamic obesity.

How similar studies have gone: Ketogenic diets are well established for pediatric drug-resistant epilepsy, but their specific use for hypothalamic obesity is novel and supported mainly by small case series and limited pilot data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosis of hypothalamic-chiasmatic tumour according to the WHO 2021 classification
2. Diagnosis of hypothalamic obesity: after 5 years of age, BMI \>97th percentile in the WHO 2007 curves
3. Males and females aged between 7 and 30 years
4. Performance status: Lansky score \> 40 for patients aged \< 18 years and Karnofsky score \> 40 for patients aged between 18 and 30 years
5. Signature of informed consent to participate in the study
6. Signature of consent by the minor patient to participate in the study (7-13 years and 14-17 years).

Exclusion Criteria:

1\. Deficiencies of:

* Primary carnitine
* Carnitine palmitoyltransferase 2 (CPT 2)
* Carnitine acylcarnitine translocase (CACT)
* Beta-oxidation
* Medium-chain acyl-CoA dehydrogenase (MCAD)
* long-chain acyl-CoA dehydrogenase (LCAD)
* short-chain acyl-CoA dehydrogenase (SCAD)
* porphyria
* pyruvate carboxylase
* long-chain 3-hydroxyacyl-CoA dehydrogenase.

Where it's running

  • Meyer Children's Hospital IRCCS
    Florence, Florence, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.